What is Medline, Inc. 's cash & equivalents?

Medline, Inc. (MDLN) reported cash & equivalents of $2.24B in Q1 2026.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Medline, Inc. MDLN Cash & Equivalents

Cash & Equivalents at other companies

Baxter InternationalBAX

$2.02B-12.1%

Becton, Dickinson and CompanyBDX

$1.02B+49.0%

Cardinal HealthCAH

$3.94B+18.4%

McKessonMCK

$3.98B-33.3%

Henry ScheinHSIC

$138M+8.7%

SolventumSOLV

$561M+5.1%

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$32.87B+5.7%

Enterprise value$43.19B—

P/E39.1×—

P/S1.2×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's cash & equivalents?: Medline, Inc. (MDLN) reported cash & equivalents of $2.24B in Q1 2026.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.